BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10586108)

  • 1. [Genetics of uterine leiomyomata].
    Pedeutour F; Ligon AH; Morton CC
    Bull Cancer; 1999 Nov; 86(11):920-8. PubMed ID: 10586108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of uterine leiomyomata.
    Ligon AH; Morton CC
    Genes Chromosomes Cancer; 2000 Jul; 28(3):235-45. PubMed ID: 10862029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leiomyomata: heritability and cytogenetic studies.
    Ligon AH; Morton CC
    Hum Reprod Update; 2001; 7(1):8-14. PubMed ID: 11212080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
    Hodge JC; Morton CC
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
    Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
    Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas.
    Schoenberg Fejzo M; Ashar HR; Krauter KS; Powell WL; Rein MS; Weremowicz S; Yoon SJ; Kucherlapati RS; Chada K; Morton CC
    Genes Chromosomes Cancer; 1996 Sep; 17(1):1-6. PubMed ID: 8889500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors.
    Kazmierczak B; Dal Cin P; Wanschura S; Borrmann L; Fusco A; Van den Berghe H; Bullerdiek J
    Genes Chromosomes Cancer; 1998 Dec; 23(4):279-85. PubMed ID: 9824199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HMGIY in three uterine leiomyomata with complex rearrangements of chromosome 6.
    Sornberger KS; Weremowicz S; Williams AJ; Quade BJ; Ligon AH; Pedeutour F; Vanni R; Morton CC
    Cancer Genet Cytogenet; 1999 Oct; 114(1):9-16. PubMed ID: 10526529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene fusion involving HMGIC is a frequent aberration in uterine leiomyomas.
    Mine N; Kurose K; Nagai H; Doi D; Ota Y; Yoneyama K; Konishi H; Araki T; Emi M
    J Hum Genet; 2001; 46(7):408-12. PubMed ID: 11450849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata.
    Xing YP; Powell WL; Morton CC
    Cancer Genet Cytogenet; 1997 Oct; 98(1):69-74. PubMed ID: 9309121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal interval defined on 7q in uterine leiomyoma.
    Sell SM; Tullis C; Stracner D; Song CY; Gewin J
    Cancer Genet Cytogenet; 2005 Feb; 157(1):67-9. PubMed ID: 15676150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic abnormalities in uterine leiomyomata.
    Rein MS; Friedman AJ; Barbieri RL; Pavelka K; Fletcher JA; Morton CC
    Obstet Gynecol; 1991 Jun; 77(6):923-6. PubMed ID: 2030869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression studies in leiomyomata: new directions for research.
    Catherino W; Salama A; Potlog-Nahari C; Leppert P; Tsibris J; Segars J
    Semin Reprod Med; 2004 May; 22(2):83-90. PubMed ID: 15164303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
    Gattas GJ; Quade BJ; Nowak RA; Morton CC
    Genes Chromosomes Cancer; 1999 Aug; 25(4):316-22. PubMed ID: 10398424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes.
    Van de Ven WJ
    Eur J Obstet Gynecol Reprod Biol; 1998 Dec; 81(2):289-93. PubMed ID: 9989879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF.
    Moore SD; Herrick SR; Ince TA; Kleinman MS; Dal Cin P; Morton CC; Quade BJ
    Cancer Res; 2004 Aug; 64(16):5570-7. PubMed ID: 15313893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of chromosomal abnormalities of chromosome 12 in uterine leiomyoma using fluorescence in situ hybridization.
    Hayashi S; Miharu N; Okamoto E; Samura O; Hara T; Ohama K
    Jpn J Hum Genet; 1996 Mar; 41(1):193-202. PubMed ID: 8914635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preliminary cytogenetic study of uterine leiomyoma].
    Xiu ZF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):91-3, 123. PubMed ID: 8344090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of HMGIC in a uterine lipoleiomyoma with a complex rearrangement including chromosomes 7, 12, and 14.
    Pedeutour F; Quade BJ; Sornberger K; Tallini G; Ligon AH; Weremowicz S; Morton CC
    Genes Chromosomes Cancer; 2000 Feb; 27(2):209-15. PubMed ID: 10612811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.